- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
BMJ ad framed as an acquisition announcement for Dificlir was ruled promotional. It lacked prescribing information and an adverse event reporting statement,…
Anonymous complaint alleged excessive rep calls, lack of SOP guidance and uncertified virtual materials (Jul 2020–Jun 2021). Panel found complainant didn’t meet…
Anonymous employee alleged improper planning/certification of advisory boards in Croatia, Poland and Hungary and conflicts of interest. Panel found allegations unproven; no…
A UK health professional challenged a GSK global LinkedIn post about positive interim Phase 2 results in a COVID-19 vaccine collaboration. Panel…
A medical oncologist alleged an AstraZeneca senior employee’s LinkedIn post promoted oncology portfolio/pipeline to the public. Panel found no direct product/pipeline promotion…
Forxiga website and rep messaging implied all patients can start 10mg with no uptitration. Key 5mg start for severe hepatic impairment was…
A hospital consultant complained about LinkedIn activity. PMCPA found breaches after an AstraZeneca employee liked/commented on a dapagliflozin post, potentially disseminating POM…
A Symbicort Turbohaler promotional email subject line omitted the non-proprietary name at first mention. PMCPA found breaches of Clauses 12.3 and 5.1,…
A Tillotts rep made an unplanned GP practice call about Asacol shortage/Octasa switch. The pharmacist said they don’t see reps, but the…
A Nilemdo press release said it “can be combined with other oral treatments” but didn’t make the simvastatin >40mg contraindication immediately apparent.…
A third-party promotional webpage had a non-functioning single-click PI link for Pradaxa/Praxbind for ~3 weeks. An earlier email alert to medical information…
Roche funded a patient organisation website update. PMCPA found the declaration of support wasn’t apparent from the start and the written grant…
A Novartis HCP website link to Tasigna “Great Britain Prescribing Information” mistakenly displayed Northern Ireland marketing authorisation numbers. The Panel ruled a…
Complaint that a Nuvaxovid (POM) web ad appeared without HCP confirmation. Panel found P3 Pharmacy could be an independently produced HCP journal…
PMCPA found Otsuka’s Jinarc training portal gave contradictory messages about enrolment being required to prescribe, and an HCP educational guide omitted a…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.